HIM
BPMC

Hillhouse Investment Management’s Blueprint Medicines BPMC Stock Holding History

Hillhouse Investment Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,430,949
Closed -$112M – 26
2018
Q3 		$112M Hold
1,430,949
– – 2.99% 8
2018
Q2 		$90.8M Buy
1,430,949
+62,500
+5% +$4.97M 1.55% 17
2018
Q1 		$125M Hold
1,368,449
– – 2.21% 11
2017
Q4 		$103M Buy
1,368,449
+769,600
+129% +$54.1M 1.75% 13
2017
Q3 		$41.7M Buy
598,849
+15,604
+3% +$834K 0.69% 20
2017
Q2 		$29.6M Sell
583,245
-150,000
-20% -$6.37M 0.46% 22
2017
Q1 		$29.3M Buy
733,245
+250,790
+52% +$8.98M 0.57% 17
2016
Q4 		$13.5M Buy
482,455
+311,840
+183% +$9.4M 0.3% 17
2016
Q3 		$5.07M Buy
170,615
+118,365
+227% +$2.94M 0.1% 30
2016
Q2 		$1.06M Buy
+52,250
New +$950K 0.03% 30

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Hillhouse Investment Management's BPMC Position: Q4 2018 in Review

Hillhouse Investment Management sold out of Blueprint Medicines (BPMC) in Q4 2018, closing a stake of 1,430,949 shares — an estimated $112M sold.

Hillhouse Investment Management first reported a position in BPMC in Q2 2016 and held it in 10 quarters. The position peaked at $125M in Q1 2018. 162 funds tracked by Wall St. Rank hold BPMC as of Q4 2018.

  • Hillhouse Investment Management reported no remaining Blueprint Medicines position as of Q4 2018 after selling out during the quarter.
  • Hillhouse Investment Management sold 1,430,949 Blueprint Medicines shares in Q4 2018, an estimated $112M.
  • Hillhouse Investment Management first reported a position in Blueprint Medicines in Q2 2016 and held it in 10 quarters.
  • Hillhouse Investment Management's Blueprint Medicines position peaked at $125M in Q1 2018.
  • 162 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2018.

Based on Hillhouse Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.